Scarica l'app Stockscreener
1.64
1.20%
-0.02
Dopo l'orario di chiusura:
1.67
0.03
+1.83%
Precedente Chiudi:
$1.66
Aprire:
$1.825
Volume 24 ore:
2.36M
Relative Volume:
10.45
Capitalizzazione di mercato:
$5.44M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-9.89%
1M Prestazione:
-78.84%
6M Prestazione:
-76.70%
1 anno Prestazione:
-90.96%
Intervallo 1D:
$1.54
$1.96
Intervallo di 1 settimana:
$1.54
$1.96
Portata 52W:
$1.54
$23.10
Metavia Inc Stock (MTVA) Company Profile
Nome
Metavia Inc
Settore
Industria
Telefono
(857) 702-9600
Indirizzo
545 CONCORD AVENUE, CAMBRIDGE
Compare MTVA vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MTVA
Metavia Inc
|
1.64 | 5.50M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Metavia Inc Stock (MTVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-04 | Ripresa | H.C. Wainwright | Buy |
| 2024-12-30 | Iniziato | H.C. Wainwright | Buy |
Metavia Inc Borsa (MTVA) Ultime notizie
How MetaVia Inc. stock performs in stagflationJuly 2025 Summary & Growth Focused Entry Point Reports - mfd.ru
MetaVia secures patent protection for obesity treatment through 2041 - Investing.com India
MetaVia secures patent protection for obesity treatment through 2041 By Investing.com - Investing.com Nigeria
Metavia builds comprehensive global patent protection for DA-1726, securing exclusive rights to novel obesity and metabolic therapy - marketscreener.com
Can MetaVia Inc. continue delivering strong returnsMarket Movers & Entry Point Confirmation Signals - mfd.ru
MetaVia Builds Comprehensive Global Patent Protection for DA-1726, Securing Exclusive Rights to Novel Obesity and Metabolic Therapy Through 2041 - PR Newswire
Will MetaVia Inc. outperform its industry peers2025 Historical Comparison & Fast Entry and Exit Trade Plans - mfd.ru
Will MetaVia Inc. stock go up in YEAROil Prices & Real-Time Volume Surge Alerts - mfd.ru
Earnings Recap: What analysts say about MetaVia Inc. stockWeekly Investment Report & Fast Gaining Stock Strategy Reports - mfd.ru
MetaVia (MTVA) Stock Price, News & Analysis - MarketBeat
Aug Drivers: Does MetaVia Inc outperform in volatile markets2025 Big Picture & Fast Momentum Entry Tips - baoquankhu1.vn
Technical Analysis: Is now the right time to enter MetaVia IncJuly 2025 Earnings & Real-Time Buy Signal Alerts - baoquankhu1.vn
AI modeling confirms therapeutic targets for MetaVia’s vanoglipel By Investing.com - Investing.com Australia
Metavia Inc announces positive AI-modeling results from ongoing SyntekaBio collaboration, confirming key therapeutic targets for Vanoglipel - marketscreener.com
AI modeling confirms therapeutic targets for MetaVia’s vanoglipel - Investing.com
Metavia IncAnnounces Positive Ai-Modeling Results From Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets For Vanoglipel - TradingView
MetaVia Announces Positive AI-Modeling Results from its Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets for Vanoglipel - ChartMill
Bear Alert: Is REVBW a potential multi baggerWall Street Watch & Momentum Based Trading Signals - baoquankhu1.vn
Breakout Watch: Is MetaVia Inc in a consolidation phase2025 Trading Recap & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Aug EndMonth: How correlated is RNAC to the S P500July 2025 Weekly Recap & Daily Stock Trend Reports - baoquankhu1.vn
MetaVia Updates 2025 Executive Discretionary Bonus Disclosure - TipRanks
Gainers Report: What is the next catalyst for MetaVia IncWatch List & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Aug Selloffs: Will MetaVia Inc benefit from seasonalityWeekly Stock Report & Weekly High Momentum Picks - baoquankhu1.vn
Market Outlook: What is the PEG ratio of MetaVia Inc2025 Short Interest & Community Verified Watchlist Alerts - baoquankhu1.vn
Aug PreEarnings: What are analysts’ price targets for SLND.WS2025 Trading Volume Trends & Fast Gain Swing Alerts - baoquankhu1.vn
Aug Decliners: Can MetaVia Inc continue delivering strong returns2025 Risk Factors & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
MTVA Stock Price, Forecast & Analysis | METAVIA INC (NASDAQ:MTVA) - Chartmill
MTVA: Positive Results for 48 mg Cohort in Phase 1b Trial of DA-1726… - Yahoo Finance
Trade Report: Can MetaVia Inc stock outperform in a bear marketJuly 2025 Rallies & Weekly Market Pulse Alerts - baoquankhu1.vn
What Does the Market Think About MetaVia Inc? - Sahm
MetaVia (NASDAQ:MTVA) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
Aug Reactions: Is SWKH impacted by rising rates2025 Support & Resistance & Momentum Based Trading Ideas - baoquankhu1.vn
Aug Update: Does MetaVia Inc have strong fundamentalsPortfolio Gains Report & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
MetaVia closes $9.3 million public offering with full exercise of option - Investing.com Nigeria
MetaVia prices $8.1M underwritten public offering - MSN
MetaVia Completes Public Offering to Advance Obesity Drug - TipRanks
MetaVia closes $9.3 million public offering with full exercise of option By Investing.com - Investing.com South Africa
MetaVia Signs Multiple Material Agreements - TradingView
MetaVia Announces the Closing of $9.3 Million Underwritten Public Offering, Including Full Exercise of Allotment Option - PR Newswire
Stop Loss: What is the target price for MetaVia Inc stockTrend Reversal & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
MetaVia prices $8.1 million public offering to fund obesity treatment By Investing.com - Investing.com Nigeria
MetaVia Stock Slides After Pricing Public Offering - Nasdaq
MetaVia Inc. Prices Public Offering, Raising $8.1 Million - Intellectia AI
MetaVia prices $8.1 million public offering to fund obesity treatment - Investing.com
U.S. farmers grow wary as Ag Economy Barometer falls to 100 in August 2024 - Stock Titan
Rally Mode: Is MetaVia Inc stock showing strong momentumWeekly Trade Report & Intraday High Probability Setup Alerts - baoquankhu1.vn
Aug Retail: What catalysts could drive MetaVia Inc stock higherLayoff News & Real-Time Price Movement Reports - Bộ Nội Vụ
MetaVia’s DA-1726 shows early promise in obesity treatment - Longevity.Technology
What risks investors should watch in MetaVia Inc. stock2025 Price Targets & Entry and Exit Point Strategies - Улправда
Research Analysts Issue Forecasts for MetaVia Q4 Earnings - Defense World
VIX Spike: Why retail investors favor MetaVia Inc stock2025 Winners & Losers & Low Risk High Reward Ideas - moha.gov.vn
Metavia Inc Azioni (MTVA) Dati Finanziari
Non sono disponibili dati finanziari per Metavia Inc (MTVA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Metavia Inc Azioni (MTVA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| DONG-A ST CO., LTD | 10% Owner |
May 08 '25 |
Buy |
0.71 |
4,647,887 |
3,300,000 |
9,995,679 |
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):